ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2021 and some content may be unavailable. To unlock all content for 2021, please visit the archives.

Abstract: PO0665

Identification of Cell-Specific Transcriptomic Changes and Cross-Talk in Diabetic Mice with Podocyte-Specific Induction of KLF6 Using Single Nuclei RNA Sequencing

Session Information

Category: Diabetic Kidney Disease

  • 601 Diabetic Kidney Disease: Basic

Authors

  • Owusu Frimpong, Bismark, Stony Brook University Renaissance School of Medicine, Stony Brook, New York, United States
  • Gujarati, Nehaben A., Stony Brook University Renaissance School of Medicine, Stony Brook, New York, United States
  • Mallipattu, Sandeep K., Stony Brook University Renaissance School of Medicine, Stony Brook, New York, United States
Background

Krüppel-Like Factor 6 (KLF6), a zinc finger transcription factor, is a key regulator of cytochrome c oxidase assembly in the podocytes. We previously reported that podocyte-specific loss of KLF6 exacerbates diabetic kidney disease (DKD). However, the role of podocyte-specific induction of human KLF6 in DKD remains unexplored.

Methods

A combination of unilateral nephrectomy and streptozotocin (UNx-STZ) was utilized to induce DKD in mice. Using the “Tet-on” system, mice with podocyte-specific induction of human KLF6 (hKLF6PODTA) were generated by crossing NPHS2-rtTA mice with tre-hKLF6 mice and fed with doxycycline-containing diet. UNx-STZ-NPHS2-rtTA and SHAM UNx-Veh mice served as diabetic and non-diabetic controls, respectively. Single nucleus (sn)RNA-seq libraries were prepared from kidney cortex using the 10X Chromium System. Raw sequencing data was aligned to mouse pre-mRNA reference genome using Cell Ranger. Quality control, dimensionality reduction and clustering were performed using the R-package, Seurat.

Results

23 clusters were generated using unsupervised clustering analysis. Enrichment and pathway analyses showed a downregulation of injury-related pathways such as inflammatory and interleukin signaling in the UNx-STZ-treated hKLF6PODTA group across the podocyte, endothelial cell, mesangial cell, and proximal tubular clusters, compared to the UNx-STZ-treated NPHS2-rtTA group. Conversely, metabolic pathways such as oxidative phosphorylation and fatty acid metabolism were upregulated. A cross-reference of the differentially expressed genes (DEGs) in the podocyte cluster of the UNx-STZ-treated hKLF6PODTA group with a KLF6 ChIP-seq data set revealed the presence of putative KLF6 binding sites in the regulatory regions of several DEGs. A unique proximal tubule (PT) cluster with distinctive gene expression signature was identified in the hKLF6PODTA group, suggesting an intercellular communication between podocytes and the PT cells in the hKLF6PODTA group that mediates the progression of DKD.

Conclusion

SnRNA-seq demonstrates potential mechanisms by which podocyte-specific induction of KLF6 attenuates the progression of DKD.

Funding

  • NIDDK Support